Study links migraine drug to higher kidney stone risk

04/9/2013 | MedPage Today (free registration)

Taking the migraine drug topiramate was associated with lower urinary citrate excretion, putting patients at risk for kidney stones, according to a study presented at the National Kidney Foundation 2013 Spring Clinical Meetings. "Hypocitraturia from topiramate is rapid and progressive," researcher Allan Jhagroo said. "This should be taken into account when starting therapy, particularly in patients with a history of urolithiasis or with identifiable lithogenic risk factors."

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President, Science and Regulatory Affairs
American Beverage Association
Washington, DC
Senior Manager of Medical Management
Network Health
Medford, MA
MEDICAL SCIENCE LIAISON - 14000002RO
Abbott
Columbus, OH
Manager, Medical Management
Network Health
Medford, MA
Medical Director - Cataract
Abbott
Santa Ana, CA